Genotype Single Infection Single % Multiple Infection Multiple % Total Total %
6 20 4.00 10 2.00 30 6.00
9 1 0.20 0 0.00 1 0.20
11 1 0.20 0 0.00 1 0.20
16 59 11.80 33 6.60 92 18.40
18 13 2.60 11 2.20 24 4.80
31 11 2.20 6 1.20 17 3.40
33 6 1.20 7 1.40 13 2.60
35 3 0.60 2 0.40 5 1.00
39 7 1.40 1 0.20 8 1.60
40 1 0.20 2 0.40 3 0.60
42 4 0.80 2 0.40 6 1.20
45 9 1.80 5 1.00 14 2.80
51 21 4.20 17 3.40 38 7.60
52 28 5.60 22 4.40 50 10.00
53 16 3.20 9 1.80 25 5.00
54 6 1.20 10 2.00 16 3.20
55 1 0.20 3 0.60 4 0.80
56 5 1.00 0 0.00 5 1.00
58 14 2.80 8 1.60 22 4.40
59 17 3.40 10 2.00 27 5.40
61 13 2.60 11 2.20 24 4.80
62 12 2.40 3 0.60 15 3.00
66 5 1.00 5 1.00 10 2.00
67 2 0.40 1 0.20 3 0.60
68 3 0.60 0 0.00 3 0.60
69 1 0.20 0 0.00 1 0.20
70 3 0.60 2 0.40 5 1.00
71 3 0.60 0 0.00 3 0.60
72 5 1.00 2 0.40 7 1.40
73 4 0.80 0 0.00 4 0.80
81 5 1.00 0 0.00 5 1.00
83 3 0.60 3 0.60 6 1.20
84 4 0.80 5 1.00 9 1.80
CP6108 2 0.40 1 0.20 3 0.60
IS39 1 0.20 0 0.00 1 0.20
Total 309 61.80 191 38.20 500 100
Table 2: Human Papilloma Virus (HPV) genotyping of single or multiple infections in 309 women with detectable HPV DNA. Percentage is calculated with respect to totalized 500 positive HPV ID’s.